Background and Objectives: Cytokines in platelet concentrates contribute to febrile transfusion reactions. Activated monocytes are a major source of inflammatory cytokines, however the role of monocytes in cytokine production in platelet concentrates has not been clarified. This study undertook to quantitate monocytes, determine whether monocyte activation occurs and identify an association with IL-6 and IL-1β concentrations in platelet concentrates. Materials and Methods: 17 platelet concentrates were analysed for total leucocyte and monocyte counts, CD14 and CD16 monocyte-associated antigen expression and IL-1β and IL-6 measurements on days 1, 2, 3, 4 and 5. Results: Monocytes in all platelet concentrates expressed increased levels of CD14 and CD16 from day 1 of storage. 10/17 platelet concentrates had elevated IL-6 levels by day 3. Platelet concentrates with IL-6 levels above 15 pg/ml on day 5 had monocyte counts between 0.14 and 15.6 × 106/unit on day 1, while those with IL-6 levels below 15 pg/ml had low monocyte counts of < 0.01 to 1.2 × 106/unit on day 1. Conclusion: Monocytes present in platelet concentrates exhibit features of activation. Monocyte activation is present following the preparation of platelet concentrates, implicating the manufacturing process in its development. Increased IL-6 and IL-1β levels during platelet concentrate storage are commonly associated with a higher monocyte count. However, no direct association could be identified between the extent of monocyte activation and the level of cytokine release.

1.
Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME: Increased tumour necrosis factor α (TNFα), interleukin 1 and interleukin 6 (IL-6) levels in plasma of stored platelet concentrates: Relationship between TNFα and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195–199.
2.
Heddle NM, Klama LM, Griffith L, Roberts R, Shukla G, Kelton JG: A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993;33:794–797.
3.
Muylle L, Wouters E, De Bock R, Peetermans ME: Reactions to platelet transfusion: The effect of the storage time of the concentrate. Transfus Med 1992;2:289–293.
4.
Wadhwa M, Seghatchian MJ, Lubenko A, Contreras M, Dilger P, Bird C, Thorpe R: Cytokine levels in platelet concentrates: Quantitation by bioassays and immunoassays. Br J Haematol 1996;93:225–234.
5.
Aye MT, Palmer DS, Giulivi A, Hashemi S: Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;35:117–124.
6.
Dinarello CA: Biology of interleukin-1. FASEB J 1988;2:108–115.
7.
Callard R, Gearing A: The Cytokine Facts Book. London, Academic Press, 1994, p 64.
8.
Ferrara J: The febrile platelet transfusion reaction: A cytokine shower. Transfusion 1995;35:89–90.
9.
Ziegler-Heitbrock HWL: Heterogeneity of human blood monocytes: The CD14+CD16+ subpopulation. Immunol Today 1996;17:424–428.
10.
Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M, Ziegler-Heitbrock HWL: The novel subset of CD14+CD16+ blood monocytes is expanded in sepsis patients. Blood 1993;82:3170–3176.
11.
Molloy RG, Mannick JA, Rodrick ML: Cytokines, sepsis and immunomodulation. Br J Surg 1993;80:289–297.
12.
Hawrylowicz CM, Howells GL, Feldman M: Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med 1991;174:785–790.
13.
Lund-Johansen F, Olweus J: Signal transduction in monocytes and granulocytes measured by multiparameter flow cytometry. Cytometry 1992;13:693–702.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.